Effects of magnesium sulfate infusion upon clotting parameters in patients with pre-eclampsia

Journal of Perinatal Medicine

Volumn 26, Issue 2, 1998, Pages 115-119

  Assaley, Joseph ^a   Baron, Joseph M ^a   Cibils, Luis A ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Bleeding time; Blood clotting factors; Magnesium sulfate; Pre eclampsia

Indexed keywords

MAGNESIUM SULFATE;

ADULT; BLEEDING TIME; BLOOD CLOTTING; CLINICAL ARTICLE; CONVULSION; FEMALE; HUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SHORT SURVEY; THROMBOCYTE COUNT;

EID: 0031955280     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpme.1998.26.2.115     Document Type: Short Survey

References (22)

1. Baker W, B Kort, RC Cefalo: Effects of plasma on the platelet anti-aggregatory action of prostacyclin in pregnancy. Am J Obstet Gynecol 156 (1987) 974
2. Beaufils M, S Uzan, R Donsimoni, JC Colau: Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1 (1985) 840
3. Bussolino F, C Benedetto, M Massobrio, G Camussi: Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 2 (1980) 702
4. Fitzgerald DJ, GA Fitzgerald: Eicosanoids in the pathogenesis of pre-eclampsia. In: LARAGH JH, BM BRENNER (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, Raven Press, Ltd, (1990) 1789
5. Kelton JG, JS Hunter, PB Neame: A platelet function defect in pre-eclampsia. Obstet Gynecol 65 (1985) 107
6. Kynczl-Leisure M, LA Cibils: Increased bleeding time following magnesium sulfate infusions. Am J Obstet Gynecol 175 (1996) 1293
7. Mielke CH, MM Kaneshiro, IA Maker et al: The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 34 (1969) 204
8. Moncada S, JR Vane: Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 300 (1979) 1142
9. Musotti G, G Galanti, L Poggin, R Abbate: Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 2 (1979) 1213
10. NEN Products, Catalog No. NEK 007-007A, and 008-008A. I. E. DuPont de Nemours and Co (Inc), Medical Products Department, Boston, Massachusetts
11. Ogburn PL, PP Williams, SB Johnson, PT Holman: Serum arachidonic acid levels in normal and preeclamptic pregnancies. Am J Obstet Gynecol 148 (1984) 5
12. Ramanathan J, BM Sibai, T Vu, D Chauhan: Correlation between bleeding times and platelet counts m women with pre-eclampsia undergoing cesarean section. Anesthesiology 71 (1989) 188
13. Remuzzi G, D Marchesi, C Zoja, et al: Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 20 (1980) 105
14. nd edition. Philadelphia, WB Saunders, (1986) 777
15. Rowland RC, JA Pritchard:The effect of parenteral magnesium sulfate therapy on blood loss at delivery. Am J Obstet Gynecol 89 (1964) 261
16. nd edition. New York, Churchill Livingston (1991) 993
17. 2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 321 (1989) 351
18. Schindler M, S Gatt, P Isert et al: Thrombocytopenia and platelet functional defects in pre-eclampsia: implications for regional anaesthesia. Anaesth Intens Care 18 (1990) 169
19. Triplett DA, CS Harms, P Newhouse, C Clark: Platelet function. Laboratory evaluation and clinical application. ASCP, Chicago 1978
20. Wallenburg HCS, GA Dekker, LW Makovitz, P Rotmans: Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1 (1986) 1
21. Wang Y, SW Walsh, J Guo, J Zhang: The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 165 (1991) 1695
22. Watson KV, CF Muldow, PL Ogburn, HS Jacob: Magnesium sulfate: rationale for its use in preeclampsia. Proc Natl Acad Sci USA 83 (1986) 1075